United States - English - NLM (National Library of Medicine)

slv pharmaceuticals llc dba aum pharmaceuticals - folic acid (unii: 935e97boy8) (folic acid - unii:935e97boy8), iron pentacarbonyl (unii: 6wq62taq6z) (ferrous cation - unii:gw89581owr), cyanocobalamin (unii: p6yc3eg204) (cyanocobalamin - unii:p6yc3eg204), ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r) - neonatal fe rx prenatal vitamin with ferronyl iron vitamin is indicated for the treatment of all anemias that are responsive to oral iron therapy. these include: hypochromic anemia associated with pregnancy, chronic and/or acute blood loss, metabolic disease, postsurgical convalescence, and dietary needs. hypersensitivity to any of the ingredients. hemolytic anemia, hemochromatosis, and hemosiderosis are contraindications to iron therapy.

Australia - English - Department of Health (Therapeutic Goods Administration)

device technologies australia pty ltd - 58703 - neonatal/paediatric heart rate monitoring application software - hero is intended to acquire, store, analyze, and report on ecg data collected from infants. hero is intended to be used by trained operators under the direct supervision of a licensed health care practitioner in a hospital neonatal or pediatric icu environment. hero is intended to be used for the analysis of the variability in rr intervals (heart rate) and to report measurements of the variability of heart rate data (hrv). the hrv measurements reported by hero are specialized in nature, and intended to identify periods of transient decelerations and/or reduced baseline variability in the heart rate. hero is intended to provide specialized hrv measurements and may detect arrhythmias, that when combined with other risk factors, can be used as an aid in assessing the risk of sepsis in infants. the use of the hero monitoring improves survival in very low birth weight neonates.

United States - English - NLM (National Library of Medicine)

neomed pharmaceutical - vitamin a (unii: 81g40h8b0t) (vitamin a - unii:81g40h8b0t), ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), cholecalciferol (unii: 1c6v77qf41) (cholecalciferol - unii:1c6v77qf41), .alpha.-tocopherol acetate (unii: 9e8x80d2l0) (.alpha.-tocopherol - unii:h4n855pnz1), thiamine (unii: x66nso3n35) (thiamine ion - unii:4abt0j945j), riboflavin (unii: tlm2976ofr) (riboflavin - unii:tlm2976ofr), niacinamide (unii: 25x51i8rd4) (niacinamide - unii:25x51i8rd4), pyridoxine hydrochloride (unii: - neonatal plus tablet  rx is a multi-vitamin/mineral prescription drug indicated for use in improving the nutritional status of women prior to conception, throughout pregnancy, and in the postnatal period for both lactating and nonlactating mothers. this product is contraindicated in patients with a known hypersensitivity to any of the ingredients.

United States - English - NLM (National Library of Medicine)

slv pharmaceuticals llc dba aum pharmaceuticals - beta carotene (unii: 01yae03m7j) (.beta.-carotene - unii:01yae03m7j), ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), cholecalciferol (unii: 1c6v77qf41) (cholecalciferol - unii:1c6v77qf41), .alpha.-tocopherol acetate, dl- (unii: wr1wpi7ew8) (.alpha.-tocopherol, dl- - unii:7qwa1rio01), thiamine mononitrate (unii: 8k0i04919x) (thiamine ion - unii:4abt0j945j), riboflavin (unii: tlm2976ofr) (riboflavin - unii:tlm2976ofr), niacinamide (unii: 25x51i8rd4) (niacinamide - unii:25x51i8rd4), - neonatal complete is a multi-vitamin/mineral prescription drug indicated for use in improving the nutritional status of women prior to conception, throughout pregnancy, and in the postnatal period for both lactating and nonlactating mothers. this product is contraindicated in patients with a known hypersensitivity to any of the ingredients.

United States - English - NLM (National Library of Medicine)

slv pharmaceuticals llc dba aum pharmaceuticals - beta carotene (unii: 01yae03m7j) (.beta.-carotene - unii:01yae03m7j), ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), cholecalciferol (unii: 1c6v77qf41) (cholecalciferol - unii:1c6v77qf41), .alpha.-tocopherol acetate, dl- (unii: wr1wpi7ew8) (.alpha.-tocopherol, dl- - unii:7qwa1rio01), thiamine mononitrate (unii: 8k0i04919x) (thiamine ion - unii:4abt0j945j), riboflavin (unii: tlm2976ofr) (riboflavin - unii:tlm2976ofr), niacinamide (unii: 25x51i8rd4) (niacinamide - unii:25x51i8rd4), - neonatal dha is a multi-vitamin/mineral prescription drug indicated for use in improving the nutritional status of women prior to conception, throughout pregnancy, and in the postnatal period for both lactating and nonlactating mothers. this product is contraindicated in patients with a known hypersensitivity to any of the ingredients.

Australia - English - Department of Health (Therapeutic Goods Administration)

device technologies australia pty ltd - 65875 - neonatal cpap nasal mask holder - a device intended to hold a cpap mask/cannula in place on a neonatal/infant patient during a cpap therapy/non-invasive ventilation therapy.

Australia - English - Department of Health (Therapeutic Goods Administration)

device technologies australia pty ltd - 14361 - ventilator, neonatal/paediatric - neonatal , paediatric ventilation of intensive care patients

Australia - English - Department of Health (Therapeutic Goods Administration)

device technologies australia pty ltd - 61197 - neonatal cpap unit - medin cpap devices and consumables are used to administer cpap therapy to premature infants and newborns.

Australia - English - Department of Health (Therapeutic Goods Administration)

australasian medical & scientific ltd - 61637 - neonatal pulmonary surfactant catheter - intended to be introduced into the trachea of a neonate for the administration of exogenous surfactant as part of pulmonary surfactant therapy. it is usually used to treat neonates at a high-risk of infant respiratory distress syndrome [surfactant deficiency disorder (sdd)]

Australia - English - Department of Health (Therapeutic Goods Administration)

device technologies australia pty ltd - 61637 - neonatal pulmonary surfactant catheter - a sterile, single-use device intended for the treatment of preterm or full term neonates at high-risk of, or suffering from, infant respiratory distress syndrome [surfactant deficiency disorder (sdd)].